Search by Drug Name or NDC
NDC 51655-0257-52 Dicyclomine Hydrochloride 20 mg/1 Details
Dicyclomine Hydrochloride 20 mg/1
Dicyclomine Hydrochloride is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Northwind Pharmaceuticals. The primary component is DICYCLOMINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Dicyclomine is used to treat the symptoms of irritable bowel syndrome. Dicyclomine is in a class of medications called anticholinergics. It relieves muscle spasms in the gastrointestinal tract by blocking the activity of a certain natural substance in the body.
Related Packages: 51655-0257-52Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Dicyclomine
Product Information
| NDC | 51655-0257 |
|---|---|
| Product ID | 51655-257_f6cbc747-b23b-3f6d-e053-6294a90a9f71 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Dicyclomine Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Dicyclomine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/1 |
| Substance Name | DICYCLOMINE HYDROCHLORIDE |
| Labeler Name | Northwind Pharmaceuticals |
| Pharmaceutical Class | Anticholinergic [EPC], Cholinergic Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA085223 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 51655-0257-52 (51655025752)
| NDC Package Code | 51655-257-52 |
|---|---|
| Billing NDC | 51655025752 |
| Package | 30 TABLET in 1 BOTTLE, PLASTIC (51655-257-52) |
| Marketing Start Date | 2021-02-17 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |